Mission
Our mission is to transform
the standard of care for people living with colorectal cancer
We are developing oncolytic immunotherapies to expand the treatment options for people living with colorectal cancer. Our aim is to develop medicines that can directly attack a patient’s tumor while potentially reducing the need for surgical interventions, helping patients to preserve colorectal function and to improve their quality of life.
Our Core Values
Passionately Patient-Centric
We are committed to delivering truly groundbreaking therapeutics that reshape the standard of care & profoundly improve the lives of the cancer patients we serve.
Boldly Entrepreneurial
We are committed to creating value for all Akamis Bio stakeholders via a combination of ruthless prioritization, capital efficiency, and a willingness to take calculated risks.
Purposefully Urgent
We are committed to operating with a sense of urgency which enables us to efficiently deliver for our stakeholders with a balance of speed, quality, and impact.
Fundamentally Performance Driven
We are committed to holding ourselves and one another accountable for delivering against goals, while recognizing, celebrating, and rewarding truly exceptional performance.
Deeply Focused on Our People
We are committed to fostering a supportive work environment where you can be your authentic self while learning, growing and developing as a professional.
Akamis Bio is a team of scientists, clinicians, and innovators united by a single goal: to improve the lives of people living with colorectal cancer.